Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Interest ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Short-Term Debt issuances (2016)

Historic Short-Term Debt issuances for Marker Therapeutics (MRKR) over the last 1 years, with Q1 2016 value amounting to -$25000.0.

  • Marker Therapeutics' Short-Term Debt issuances changed N/A to -$25000.0 in Q1 2016 from the same period last year, while for Dec 2016 it was -$25000.0, marking a year-over-year change of. This contributed to the annual value of -$25000.0 for FY2016, which is N/A changed from last year.
  • Marker Therapeutics' Short-Term Debt issuances amounted to -$25000.0 in Q1 2016.
  • Marker Therapeutics' 5-year Short-Term Debt issuances high stood at -$25000.0 for Q1 2016, and its period low was -$25000.0 during Q1 2016.